TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
LEGN

Legend Biotech Corp

Healthcare · Biotechnology

19.90$ +5.7% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Legend Biotech Corp (LEGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,751 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LEGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,839 1,849 1,775 1,798 1,736 1,670 1,616 1,690 1,713 1,734 1,597 1,751
1,509 1,498 1,414 1,425 1,350 1,284 1,219 1,250 1,242 1,247 1,083 1,227
963 1,278 898 201 459 287 442 267 279 902 646 673
1,424 1,309 1,302 1,292 1,212 1,123 1,005 968 993 949 835 965
50 157 78 101 104 125 167 229 203 250 187 198
18 19 22 19 24 24 31 36 29 32 37 42
140 4.1 169 147 175 174 185 201 206 75 35 50
500 597 611 639 620 630 598 654 702 732 629 521
175 216 250 294 271 278 234 265 434 636 509 404
2.9 3.2 3.1 3.3 4.3 4.8 5.3 5.9 150 327 277 168
17 20 39 39 27 37 58 75 102 81 74 77
276 281 286 292 297 301 306 310 172 – – –
1,340 1,251 1,164 1,159 1,116 1,041 1,018 1,036 1,011 1,002 968 1,230
-1,340 -1,485 -1,545 -1,563 -1,688 -1,662 -1,763 -1,888 -1,928 -1,959 -2,013 -1,980
182 182 182 183 183 183 184 184 185 185 185 194

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?